drugset / Trial / NCT05957380
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a multi-center, double-blind, active-controlled, randomized, parallel clinical study to evaluate the efficacy and safety of DA-2803 in chronic hepatitis B subjects
Timeline
- Start
- 2023-03-20
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-2803 | Unknown | — | Oral |
| Subject | DA-2803-R | Unknown | — | Oral |